Results for: IQVIA

RBC Capital Markets has initiated coverage on IQVIA Holdings Inc. (IQV) with an Outperform rating and a price target of $275. The analyst believes IQVIA’s vast data assets and strong competitive positioning will drive significant earnings growth in the coming years, despite recent headwinds from the COVID-19 pandemic. The company’s unique data collection and expertise in drug development are expected to position it for continued success.

IQVIA Holdings (IQV) exceeded earnings estimates in the second quarter of 2024, but recent revisions to future earnings expectations suggest a more cautious outlook. While the stock has outperformed the S&P 500 in recent weeks, investors may want to consider the broader trends before making any decisions.